The role of the free energy landscape in Parkin's function and dysfunction in health and disease
The role of the free energy landscape in Parkin's function and dysfunction in health and disease
批准号:
9883915
负责人:
A. JOSHUA WAND
金额:
$32.69万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-01 至 2024-02-28
关键词:
AddressAllosteric RegulationBindingBinding ProteinsBiologicalBiologyCalorimetryCardiacCardiomyopathiesCatalytic DomainCharacteristicsClinicClinicalCompetenceComplexCouplingDataDefectDiseaseDissectionElementsEntropyEnzymatic BiochemistryEnzymesEukaryotaExonsFluorescenceFoundationsFree EnergyFunctional disorderGoalsHealthHeart DiseasesHydration statusHydrogenInterventionKnowledgeLeadLinkMalignant NeoplasmsMass Spectrum AnalysisMeasuresMethodsMicellesMitochondriaModernizationMolecular ConformationMonitorMutagenesisMutationMyocardiumNMR SpectroscopyNeurologicNeuronsPINK1 geneParkin geneParkinson DiseasePathologicPhosphotransferasesPoint MutationPost-Translational Protein ProcessingProcessProteinsProxyRegulationRegulatory ElementRelaxationRelaxation TechniquesRepressionRoleSignal TransductionSiteStructureStructure-Activity RelationshipTertiary Protein StructureTestingThermodynamicsUbiquitinWaterbasebiophysical techniquesdisease-causing mutationearly onsethuman diseaseinsightmembermitochondrial autophagymolecular recognitionmutantnervous system disordernovelparkin gene/proteinproteostasissingle moleculesmall moleculeubiquitin ligaseubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The RING ubiquitin E3 ligases are a superfamily of proteins critical to protein homeostasis and signaling in
eukaryotes. Dysfunctions in E3 ligases are implicated in innumerable human diseases. This proposal focuses
on the regulation of the ubiquitin E3 ligase Parkin. Parkin is central to the controlled destruction of
damaged mitochondria by autophagy (mitophagy). Controlled mitophagy is particularly essential to cardiac
and neuronal health. Uncontrolled mitophagy due to mutations in Parkin is clearly a driver of early onset
Parkinson's disease (eoPD). Parkin is now implicated in a number of other neurological diseases,
cardiomyopathy and in various cancers. The central goal here is to create an understanding the physical
basis for regulation of Parkin and how clinically observed mutations promote unregulated activity leading to
inadequately controlled mitophagy and other biological defects.
Though much is known about the biology and structural basis of Parkin function, very little is certain about
the physical basis for its regulation. Parkin activity is suppressed by its intra-molecular association with a
ubiquitin-like domain and is allosterically activated by the binding of phosphorylated ubiquitin (pUb).
Phosphorlyation of the Ubl domain also promotes activation. This complicated intersection of regulatory
mechanisms can only be understood by the rigorous dissection of the underlying thermodynamics. Without
this knowledge one cannot fully interpret the effects of mutations that lead to disease.
We shall take advantage of the broad foundation of knowledge of the biology of Parkin and structural basis
of its function to address the poorly understood thermodynamics of allosteric regulation of Parkin. The basis
for regulatory control of Parkin will be cast in a modern statistical thermodynamics description of the
protein ensemble. The influence of allosteric regulators and post-translational modifications will be
examined by comprehensive hydrogen exchange monitored by mass spectrometry and NMR spectroscopy;
advanced NMR relaxation techniques; single molecule fluorescence; calorimetry; enzymology; and
mutagenesis.
A more rigorous and complete understanding of the regulation of Parkin will enable a robust interpretation
of pathological mutations. Not all pathological mutations can be simply explained as mutations that disrupt
the levels of protein or mutations that directly impact the catalytic site. Examples of common pathological
mutations will be examined to reveal the basis for their effects on Parkin's regulatory fidelity, with a longer-
range goal of determining how this impact might be mitigated by small molecule intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving Fragment Based Drug Discovery and the Development of Tools for Chemical Biology through Nanoscale Encapsulation and NMR Spectroscopy
-
批准号:10419416
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2022
-
负责人:A. JOSHUA WAND
-
依托单位:
Improving Fragment Based Drug Discovery and the Development of Tools for Chemical Biology through Nanoscale Encapsulation and NMR Spectroscopy
-
批准号:10707914
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2022
-
负责人:A. JOSHUA WAND
-
依托单位:
The role of the free energy landscape in Parkin's function and dysfunction in health and disease
-
批准号:10577825
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2020
-
负责人:A. JOSHUA WAND
-
依托单位:
The role of the free energy landscape in Parkin's function and dysfunction in health and disease
-
批准号:10356030
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2020
-
负责人:A. JOSHUA WAND
-
依托单位:
Nanoscale Encapsulation for Fragment Based Drug Discovery
-
批准号:9241998
-
项目类别:
-
资助金额:$17.51万
-
财政年份:2016
-
负责人:A. JOSHUA WAND
-
依托单位:
Sensitivity enhancement in solution NMR through dynamic nuclear polarization
-
批准号:8875018
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:A. JOSHUA WAND
-
依托单位:
Sensitivity enhancement in solution NMR through dynamic nuclear polarization
-
批准号:8575416
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:A. JOSHUA WAND
-
依托单位:
Sensitivity enhancement in solution NMR through dynamic nuclear polarization
-
批准号:8729503
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:A. JOSHUA WAND
-
依托单位:
Fluctuations and entropy in the energetics and function of protein complexes
-
批准号:8515476
-
项目类别:
-
资助金额:$35.04万
-
财政年份:2012
-
负责人:A. JOSHUA WAND
-
依托单位:
Fluctuations and entropy in the energetics and function of protein complexes
-
批准号:8345729
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2012
-
负责人:A. JOSHUA WAND
-
依托单位:
Fluctuations and entropy in the energetics and function of protein complexes
-
批准号:8664901
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2012
-
负责人:A. JOSHUA WAND
-
依托单位:
Fluctuations and entropy in the energetics and function of protein complexes
-
批准号:8878296
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2012
-
负责人:A. JOSHUA WAND
-
依托单位:
Protein dynamics, entropy and function
-
批准号:8003125
-
项目类别:
-
资助金额:$2.26万
-
财政年份:2010
-
负责人:A. JOSHUA WAND
-
依托单位:
A novel approach to integral & anchored membrane protein structure & function
-
批准号:7924975
-
项目类别:
-
资助金额:$29.19万
-
财政年份:2009
-
负责人:A. JOSHUA WAND
-
依托单位:
A novel approach to integral & anchored membrane protein structure & function
-
批准号:8134233
-
项目类别:
-
资助金额:$30.33万
-
财政年份:2008
-
负责人:A. JOSHUA WAND
-
依托单位:
A novel approach to integral & anchored membrane protein structure & function
-
批准号:7684733
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2008
-
负责人:A. JOSHUA WAND
-
依托单位:
A novel approach to integral & anchored membrane protein structure & function
-
批准号:7886817
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2008
-
负责人:A. JOSHUA WAND
-
依托单位:
A novel approach to integral & anchored membrane protein structure & function
-
批准号:7507689
-
项目类别:
-
资助金额:$30.99万
-
财政年份:2008
-
负责人:A. JOSHUA WAND
-
依托单位:
NMR spectroscopy of proteins in low viscosity fluids
-
批准号:6318674
-
项目类别:
-
资助金额:$44.57万
-
财政年份:2001
-
负责人:A. JOSHUA WAND
-
依托单位:
NMR spectroscopy of proteins in low viscosity fluids
-
批准号:6636609
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2001
-
负责人:A. JOSHUA WAND
-
依托单位:
海外基金